Pennant Capital Management’s Amgen AMGN Stock Holding History

Pennant Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-132,000	Closed	-$20.3M	–	37
2015 Q2	$20.3M	Buy	132,000 +2,000	+2%	+$320K	0.4%	33
2015 Q1	$20.8M	Buy	130,000 +3,000	+2%	+$472K	0.39%	38
2014 Q4	$20.2M	Sell	127,000 -33,000	-21%	-$5.14M	0.38%	37
2014 Q3	$22.5M	Sell	160,000 -76,000	-32%	-$9.92M	0.39%	36
2014 Q2	$27.9M	Buy	236,000 +86,000	+57%	+$9.96M	0.5%	36
2014 Q1	$18.5M	Buy	150,000 +80,000	+114%	+$9.7M	0.31%	39
2013 Q4	$7.99M	Sell	70,000 -20,000	-22%	-$2.28M	0.14%	44
2013 Q3	$10.1M	Sell	90,000 -65,000	-42%	-$7.05M	0.18%	44
2013 Q2	$15.3M	Buy	+155,000	New	+$16.1M	0.28%	41

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pennant Capital Management's AMGN Position: Q3 2015 in Review

Pennant Capital Management sold out of Amgen (AMGN) in Q3 2015, closing a stake of 132,000 shares — an estimated $20.3M sold.

Pennant Capital Management first reported a position in AMGN in Q2 2013 and held it in 9 quarters. The position peaked at $27.9M in Q2 2014. 1,380 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

Pennant Capital Management reported no remaining Amgen position as of Q3 2015 after selling out during the quarter.
Pennant Capital Management sold 132,000 Amgen shares in Q3 2015, an estimated $20.3M.
Pennant Capital Management first reported a position in Amgen in Q2 2013 and held it in 9 quarters.
Pennant Capital Management's Amgen position peaked at $27.9M in Q2 2014.
1,380 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on Pennant Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.